Periodic Reporting for period 1 - SYNKIT (Synthetic Natural Killer Cells for Immunotherapy)

Cancer remains a leading cause of death worldwide, urging for the development of innovative therapies to help patients. Recent advances have shown that infusion of immune cells, which possess an intrinsic capacity to fight cancer such as T cells or natural killer (NK) cells...